4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
EMERYVILLE, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics, Inc. (Nasdaq:FDMT), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market diseases, announced today that it priced an upsized underwritten public offering of 6,586,015 shares of its common stock at a public offering price of $29.50 per share and, in lieu of shares of common stock, to certain investors, pre-funded warrants to purchase 3,583,476 shares of common stock at a public offering price of $29.4999, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each pre-funded warrant. In addition, 4D Molecular Therapeutics has granted the underwriters a 30-day option to purchase up to an additional 1,525,423 shares of common stock at the public offering price, less underwriting discounts and commissions. The gross proceeds from the offering are expected to be approximately $300 million before deducting underwriting discounts and commissions and other offering expenses, excluding any exercise of the underwriters’ option to purchase additional shares and excluding the exercise of any pre-funded warrants. All of the shares and pre-funded warrants in the offering are to be sold by 4D Molecular Therapeutics. The offering is expected to close on February 9, 2024, subject to satisfaction of customary closing conditions.
Related news for (FDMT)
- Closing Bell Heat Check: Biotech Breakouts, Reverse Mergers & Moonshot Setups Heading into After-Hours
- Trade These, Not Those: Capital is Rotating and Here’s Where It’s Headed
- MoBot alert highlights: NASDAQ: CONI, NASDAQ: NAMM, NASDAQ: FDMT, NASDAQ: RAYA, NASDAQ: ADAP (08/01/25 04:00 AM)
- MoBot alert highlights: NASDAQ: MWYN, NASDAQ: NAMM, NASDAQ: IMG, NASDAQ: FDMT, NASDAQ: CETX (07/31/25 07:00 PM)
- MoBot alert highlights: NASDAQ: MWYN, NASDAQ: NAMM, NASDAQ: IMG, NASDAQ: FDMT, NASDAQ: CETX (07/31/25 06:00 PM)